治験用包装市場：包装タイプ、素材タイプ、エンドユーザー別-2025-2030年の世界予測

治験用包装市場は、2023年に12億6,000万米ドルと評価され、2024年には13億6,000万米ドルに達すると予測され、CAGR 8.22%で成長し、2030年には21億9,000万米ドルに達すると予測されています。

治験用包装は製薬業界において、試験段階における医薬品の完全性、安全性、コンプライアンスを確保するという重要な役割を担っています。治験用包装は、治験薬の輸送や保管に必要なパッケージングソリューションの設計、開発、サプライチェーン管理をカバーしています。主な用途としては、医薬品の安全な包装、改ざん防止ラベル、患者のコンプライアンスと投与量の正確性の確保などがあります。最終用途分野には、製薬会社やバイオテクノロジー企業、委託研究機関、関連ヘルスケア施設が主に含まれます。市場成長の主な要因は、慢性疾患の増加、多様な治療ニーズ、研究開発投資の増加により、世界中で臨床試験が継続的に拡大していることです。新たなビジネスチャンスとしては、カスタマイズされたパッケージング・ソリューションを必要とする個別化医療があり、精密医療が普及するにつれて拡大しています。リアルタイムの追跡やコンプライアンス監視のためのRFID技術やスマートラベルなど、包装におけるデジタル統合も潜在的な成長の道を示しています。しかし、規制上の課題、厳格なコンプライアンス基準、洗練されたパッケージング・ソリューションの開発における高コストが制約として作用しています。さらに、世界的に規制状況が異なるため、製品の標準化が複雑化し、市場参入企業にとって課題となっています。成長機会を生かすには、環境問題への関心が高まる中、企業は持続可能で環境に優しい包装材料に注力すべきです。技術革新の分野には、追跡・監視機能を強化し、コンプライアンスと患者の安全性の両方を向上させるスマート包装技術が含まれます。この市場の性質は競争が激しく、イノベーション主導型であるため、規制上の要求や消費者の期待に応えるための技術やデザインの継続的な進歩が求められます。このような側面に適切に対処することで、企業が市場のダイナミクスの変化に機敏に対応し、研究開発に賢く投資して次世代の治験用包装ソリューションをリードすることができれば、大きなビジネスチャンスにつながる可能性があります。

市場力学：急速に進化する治験用包装市場の主要市場インサイトを公開

治験用包装市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 臨床試験用包装の持続可能な包装に対する世界の需要の高まり
  • 臨床試験製品の保管と保護に対する需要
  • 新薬承認の増加
• 市場抑制要因
  • 発展途上地域における近代的インフラの不足
• 市場機会
  • 新薬の研究開発への投資の増加
  • スナップオフアンプルやブローフィルシールなど、革新的な医薬品包装のイントロダクション
• 市場の課題
  • 訓練を受けた人材の不足

ポーターの5つの力：治験用包装市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：治験用包装市場における外部からの影響の把握

外部マクロ環境要因は、治験用包装市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析治験用包装市場における競合情勢の把握

治験用包装市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス治験用包装市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、治験用包装市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨治験用包装市場における成功への道筋を描く

治験用包装市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臨床試験の包装における持続可能な包装の需要が世界的に高まっている
    • 臨床試験製品の保管と保護の需要
    • 新薬の承認増加
  • 抑制要因
    • 発展途上地域における近代的インフラの不足
  • 機会
    • 新薬の研究開発への投資増加
    • スナップオフアンプルやブローフィルシールなどの革新的な医薬品包装のイントロダクション
  • 課題
    • 訓練を受けた人材の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 治験用包装市場：パッケージングタイプ別

• バッグ＆ポーチ
• 水ぶくれ
• ボトル
• キットまたはパック
• サシェ
• 注射器
• チューブ
• バイアルとアンプル

第7章 治験用包装市場素材タイプ別

• コルゲートファイバー
• ガラス
• 金属
• 紙
• プラスチック

第8章 治験用包装市場：エンドユーザー別

• 臨床調査組織
• 医薬品製造施設
• 調査室

第9章 南北アメリカの治験用包装市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の治験用包装市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの治験用包装市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Alcami Corporation, Inc.
• Almac Group Limited
• Bilcare Limited
• Corden Pharma Gmbh
• Fisher Clinical Services
• Lonza Group
• Parexel International Corporation by Phoenix Parentco, Inc.
• Piramal Enterprises Ltd.
• Sharp Clinical Services, Inc
• Societal CDMO
• Symbiosis Pharmaceutical Services
• The Coghlan Group
• Westrock Company
• Xerimis Inc.
• Yourway Transport Inc.

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL PACKAGING MARKET RESEARCH PROCESS
• FIGURE 2. CLINICAL TRIAL PACKAGING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CLINICAL TRIAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CLINICAL TRIAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL PACKAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL TRIAL PACKAGING MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BAGS & POUCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BLISTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY KITS OR PACKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY VIALS & AMPOULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CORRUGATED FIBER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PAPER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY DRUG MANUFACTURING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL TRIAL PACKAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 57. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 109. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 110. ITALY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 121. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 122. POLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 124. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 125. QATAR CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM CLINICAL TRIAL PACKAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. CLINICAL TRIAL PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 154. CLINICAL TRIAL PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

The Clinical Trial Packaging Market was valued at USD 1.26 billion in 2023, expected to reach USD 1.36 billion in 2024, and is projected to grow at a CAGR of 8.22%, to USD 2.19 billion by 2030.

Clinical trial packaging plays a crucial role in the pharmaceutical industry, ensuring the integrity, safety, and compliance of drug products during testing phases. The scope of clinical trial packaging encompasses the design, development, and supply chain management of packaging solutions required for transporting and storing investigational drugs. Key applications include secure packaging of pharmaceuticals, tamper-evident labeling, and enabling patient compliance and dosage accuracy. End-use sectors predominantly involve pharmaceutical and biotechnology companies, contract research organizations, and associated healthcare facilities. A major driver for market growth is the continuous expansion of clinical trials worldwide, resulting from rising chronic diseases, diverse therapeutic needs, and increased investments in R&D. An emerging opportunity is personalized medicine requiring customized packaging solutions, which is expanding as precision medicine gains traction. Digital integration in packaging, such as RFID technology and smart labels for real-time tracking and compliance monitoring, also presents potential growth avenues. However, regulatory challenges, stringent compliance standards, and high costs in developing sophisticated packaging solutions act as limitations. Additionally, the varying global regulatory landscapes complicate product standardization, posing a challenge for market participants. To capitalize on growth opportunities, companies should focus on sustainable and eco-friendly packaging materials, as environmental concerns become more pressing. Innovation areas include smart packaging technologies that enhance tracking and monitoring capabilities, improving both compliance and patient safety. The nature of this market is highly competitive and innovation-driven, demanding continuous advancements in technology and design to meet regulatory demands and consumer expectations. Proper addressing of these aspects can lead to significant business opportunities, provided companies remain agile and responsive to changing market dynamics, investing smartly in research and development to lead in next-generation clinical trial packaging solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Packaging Market

The Clinical Trial Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for sustainable packaging for clinical trials packaging globally
  • Demand for storage and protection of clinical study products
  • Increasing approval of novel drugs
• Market Restraints
  • Dearth of modern infrastructure in developing regions
• Market Opportunities
  • Increasing investment on research and development of new drugs
  • Introduction of innovative pharmaceutical packaging, including snap off ampoules and blow fill seals
• Market Challenges
  • Dearth of trained personnel

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Packaging Market

A detailed market share analysis in the Clinical Trial Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Trial Packaging Market

A strategic analysis of the Clinical Trial Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Packaging Market, highlighting leading vendors and their innovative profiles. These include Alcami Corporation, Inc., Almac Group Limited, Bilcare Limited, Corden Pharma Gmbh, Fisher Clinical Services, Lonza Group, Parexel International Corporation by Phoenix Parentco, Inc., Piramal Enterprises Ltd., Sharp Clinical Services, Inc, Societal CDMO, Symbiosis Pharmaceutical Services, The Coghlan Group, Westrock Company, Xerimis Inc., and Yourway Transport Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Packaging Type, market is studied across Bags & Pouches, Blisters, Bottles, Kits or Packs, Sachets, Syringes, Tubes, and Vials & Ampoules.
• Based on Material Type, market is studied across Corrugated Fiber, Glass, Metal, Paper, and Plastic.
• Based on End-User, market is studied across Clinical Research Organization, Drug Manufacturing Facilities, and Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for sustainable packaging for clinical trials packaging globally
    • 5.1.1.2. Demand for storage and protection of clinical study products
    • 5.1.1.3. Increasing approval of novel drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Dearth of modern infrastructure in developing regions
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment on research and development of new drugs
    • 5.1.3.2. Introduction of innovative pharmaceutical packaging, including snap off ampoules and blow fill seals
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of trained personnel
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Trial Packaging Market, by Packaging Type

• 6.1. Introduction
• 6.2. Bags & Pouches
• 6.3. Blisters
• 6.4. Bottles
• 6.5. Kits or Packs
• 6.6. Sachets
• 6.7. Syringes
• 6.8. Tubes
• 6.9. Vials & Ampoules

7. Clinical Trial Packaging Market, by Material Type

• 7.1. Introduction
• 7.2. Corrugated Fiber
• 7.3. Glass
• 7.4. Metal
• 7.5. Paper
• 7.6. Plastic

8. Clinical Trial Packaging Market, by End-User

• 8.1. Introduction
• 8.2. Clinical Research Organization
• 8.3. Drug Manufacturing Facilities
• 8.4. Research Laboratories

9. Americas Clinical Trial Packaging Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Clinical Trial Packaging Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trial Packaging Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alcami Corporation, Inc.
• 2. Almac Group Limited
• 3. Bilcare Limited
• 4. Corden Pharma Gmbh
• 5. Fisher Clinical Services
• 6. Lonza Group
• 7. Parexel International Corporation by Phoenix Parentco, Inc.
• 8. Piramal Enterprises Ltd.
• 9. Sharp Clinical Services, Inc
• 10. Societal CDMO
• 11. Symbiosis Pharmaceutical Services
• 12. The Coghlan Group
• 13. Westrock Company
• 14. Xerimis Inc.
• 15. Yourway Transport Inc.